Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

Phase II Trial of Combination of Elotuzumab, Lenalidomide, and Dexamethasone in High-Risk Smoldering Multiple Myeloma

Blood (2016) 128 (22): 976.

https://doi.org/10.1182/blood.V128.22.976.976

Published: 2016

Journal Articles

Sequence Impact Of Pomalidomide and Carfilzomib On Treatment Response In Relapsed Multiple Myeloma

Tomer M Mark, MD, MSc, John N. Allan, MD, Angelique Boyer, Adriana C Rossi, MD, Roger N Pearse, MD, PhD, Faiza Zafar, PA, Karen Pekle, NP, Linda Tegnestam, RN, David Jayabalan, B.S.M.S, Morton Coleman, MD, Ruben Niesvizky, MD

Blood (2013) 122 (21): 1954.

https://doi.org/10.1182/blood.V122.21.1954.1954

Published: 2013

Journal Articles

Clapd (Clarithromycin, Pomalidomide, Dexamethasone) Therapy In Relapsed Or Refractory Multiple Myeloma

Tomer M Mark, MD, MSc, Angelique Boyer, Adriana C Rossi, MD, Dennis Kwon, Roger N Pearse, MD, PhD, Faiza Zafar, PA, Karen Pekle, NP, Linda Tegnestam, RN, David Jayabalan, B.S.M.S, Scott A Ely, MD, MPH, Morton Coleman, MD, Selina Chen-Kiang, PhD, Ruben Niesvizky, MD

Blood (2013) 122 (21): 1955.

https://doi.org/10.1182/blood.V122.21.1955.1955

Published: 2013

Journal Articles

Analysis of Genetic and Predisposing Factors in Japanese Patients with Atypical Hemolytic Uremic Syndrome

Xinping Fan, MD, Yoko Yoshida, MS, Toshiyuki Miyata, PhD, Shigenori Honda, MD, PhD, Masanori Matsumoto, MD, PhD, Yoshihiro Fujimura, MD, PhD

Blood (2012) 120 (21): 3337.

https://doi.org/10.1182/blood.V120.21.3337.3337

Published: 2012

Journal Articles

ClaPD (Clarithromycin, Pomalidomide, Dexamethasone) Therapy in Relapsed or Refractory Multiple Myeloma

Tomer M Mark, MD, MSc, Angelique Boyer, Adriana C Rossi, MD, Manan Shah, Roger N Pearse, MD, PhD, Faiza Zafar, PA, Karen Pekle, NP, Linda Tegnestam, RN, Erlinda A Sacris, RN, June Greenberg, RN, Stephanie Speaker, David Jayabalan, B.S.M.S, Scott A Ely, MD, MPH, Morton Coleman, MD, Selina Chen-Kiang, PhD, Ruben Niesvizky, MD

Blood (2012) 120 (21): 77.

https://doi.org/10.1182/blood.V120.21.77.77

Published: 2012

Journal Articles

ClaPD (Clarithromycin/[Biaxin®], Pomalidomide, Dexamethasone) Therapy in Relapsed or Refractory Multiple Myeloma

Tomer M Mark, MD, MSc, Melissa Rodriguez, Manan Shah, Ryann Quinn, Jessica Campbell, Ramsey Abdullah, Roger N Pearse, MD, PhD, Faiza Zafar, PA, Karen Pekle, NP, Patrice Mignott, RN, David Jayabalan, B.S.M.S, Scott A Ely, MD, MPH, Morton Coleman, MD, Selina Chen-Kiang, PhD, Ruben Niesvizky, MD

Blood (2011) 118 (21): 635.

https://doi.org/10.1182/blood.V118.21.635.635

Published: 2011

Journal Articles

Discrepancies in Serum Free Light Chain Assays and Immunofixation for Response Evaluation and Prognostication in Plasma Cell Proliferative Disorders

Nasir Bakshi, M.D., Nahlah AlGhasham, MD, Maha Alharbi, Jalaluddin Bhuiyan, Ph.D, Ghada Elgohary, MD, Fahad Alsharief, MD

Blood (2011) 118 (21): 5099.

https://doi.org/10.1182/blood.V118.21.5099.5099

Published: 2011

Journal Articles

A Phase 1 Study of Bendamustine and Melphalan Conditioning for Autologous Stem Cell Transplant in Multiple Myeloma

Tomer M Mark, MD, MSc, Whitney Reid, Ruben Niesvizky, MD, Usama Gergis, MD, Roger N Pearse, MD, PhD, Sebastian Mayer, MD, Morton Coleman, MD, Eric J Feldman, MD, Tsiporah B. Shore, MD

Blood (2011) 118 (21): 2042.

https://doi.org/10.1182/blood.V118.21.2042.2042

Published: 2011

Journal Articles

T-Bird (thalidomide, clarithromycin/[Biaxin®], lenalidomide/[Revlimid ® ], Dexamethasone) Therapy in Newly Diagnosed Symptomatic Multiple Myeloma

Tomer M Mark, MD, MSc, Manan Shah, Melissa Rodriguez, Ryann Quinn, Roger N Pearse, MD, PhD, Faiza Zafar, PA, Karen Pekle, NP, Patrice Mignott, RN, David Jayabalan, B.S.M.S, Scott A Ely, MD, MPH, Morton Coleman, MD, Selina Chen-Kiang, PhD, Ruben Niesvizky, MD

Blood (2011) 118 (21): 2937.

https://doi.org/10.1182/blood.V118.21.2937.2937

Published: 2011

Journal Articles

Normalization of the Serum Free Light Chain (FLC) Ratio Is Associated with Superior Overall Survival among Myeloma Patients Achieving Immunofixation Negative State: Results Support Incorporation of Serum FLC Ratio in Stringent CR Definition.

Shaji Kumar, MD, Angela Dispenzieri, Dirk Larson, Colin Colby, Robert Kyle, Morie Gertz, S.Vincent Rajkumar

Blood (2008) 112 (11): 1692.

https://doi.org/10.1182/blood.V112.11.1692.1692

Published: 2008

Journal Articles

Prevalence and Cause of Death in Patients with Monoclonal Gammopathy in Atomic Bomb Survivors in Hiroshima

Kingo Fujimura, MD, PhD, Fumiyoshi Kasagi, Ph.D, Hideo Sasaki, M.D., Ph.D, Chikako Ito, M.D., Ph.D

Blood (2008) 112 (11): 2714.

https://doi.org/10.1182/blood.V112.11.2714.2714

Published: 2008

Journal Articles

A Multidisciplinary Quality Initiative for Stem Cell Transplantation in Multiple Myeloma: Outpatient Transplant with Low Therapy Related Mortality

Morie Abraham Gertz, MD, Stephen M Ansell, David Dingli, Angela Dispenzieri, Francis K. Buadi, Michelle A Elliott, Dennis A Gastineau, Suzanne R Hayman, William J Hogan, David J Inwards, Patrick B Johnston, Shaji Kumar, Martha Q Lacy, Nelson Leung, Ivana NM Micallef, Luis F Porrata, Barbara A Schafer, Robert C Wolf, Mark R Litzow

Blood (2008) 112 (11): 4440.

https://doi.org/10.1182/blood.V112.11.4440.4440

Published: 2008

Journal Articles

Treatment of Menigeal Myelomatosis with Liposomal Cytarabine (DepoCyte ® ): A Case Report

Fabio Ardizzone, Michele Sciacca, Paola Migliora, Cristina Ravanelli, Alberto Santagostino

Blood (2008) 112 (11): 5219.

https://doi.org/10.1182/blood.V112.11.5219.5219

Published: 2008

Journal Articles

Evaluation of Prognostic Factors for Malignant Transformation of Monoclonal Gammopathy of Undetermined Significance

Federico Sackmann, Claudia Corrado, Isolda Fernandez, Miguel A Pavlovsky, Pablo Mountford, Astrid Pavlovsky, Miguel Pavlovsky, Mariel Alejandre, Marco Pizzolato, Santiago Pavlovsky, MD, PhD

Blood (2008) 112 (11): 5123.

https://doi.org/10.1182/blood.V112.11.5123.5123

Published: 2008

Journal Articles

Epidemiology and Clinical Outcomes of the M-Component Immunoglobulin Types of Multiple Myeloma in an Inner City Hispanic Population.

George Nicolas Batty, MD, AACP, Jonathan Brower, Adel Aziz, MD, Neelima Maddukuri, MD, James Tadros, MD, Kyudong Uhm, MD, Michael Maroules, MD

Blood (2007) 110 (11): 4736.

https://doi.org/10.1182/blood.V110.11.4736.4736

Published: 2007

Journal Articles

Primary Amyloidosis Treated with Bortezomib with a Clinical and Radiological Response.

Veena S. Fauble, MD, Ila Shah-Reddy, MD

Blood (2006) 108 (11): 5111.

https://doi.org/10.1182/blood.V108.11.5111.5111

Published: 2006

Journal Articles

A Case of IgM- λ Waldenström’s Macroglobulinemia with Activity Against Phospholipids, Masquerading as Factor V Inhibitor.

Nagender Mankan, MD, MRCP, Mohammad Razaq, MD, Ranju Gupta, MD, Allan Reiss, MD, Anju Ohri, MD

Blood (2004) 104 (11): 4003.

https://doi.org/10.1182/blood.V104.11.4003.4003

Published: 2004

Journal Articles

Biosynthesis of factor XIII B subunit by human hepatoma cell lines

JA Nagy, P Henriksson, J McDonagh

Blood (1986) 68 (6): 1272–1279.

https://doi.org/10.1182/blood.V68.6.1272.1272

Published: 1986

Journal Articles

Induction of delta-aminolevulinic acid dehydratase in mouse Friend virus-transformed erythroleukemia cells during erythroid differentiation

CS Chang, S Sassa

Blood (1984) 64 (1): 64–70.

https://doi.org/10.1182/blood.V64.1.64.64

Published: 1984

Journal Articles

Antigen--antibody complexes related to the baboon endogenous virus in humans with acute lymphoblastic leukemia--hand mirror variant (ALL-HMC)

SA Stass, TM Phillips, OS Weislow, E Perlin, HR Schumacher

Blood (1980) 56 (4): 661–666.

https://doi.org/10.1182/blood.V56.4.661.661

Published: 1980

NARROW

Phase II Trial of Combination of Elotuzumab, Lenalidomide, and Dexamethasone in High-Risk Smoldering Multiple Myeloma

Sequence Impact Of Pomalidomide and Carfilzomib On Treatment Response In Relapsed Multiple Myeloma

Clapd (Clarithromycin, Pomalidomide, Dexamethasone) Therapy In Relapsed Or Refractory Multiple Myeloma

Analysis of Genetic and Predisposing Factors in Japanese Patients with Atypical Hemolytic Uremic Syndrome

ClaPD (Clarithromycin, Pomalidomide, Dexamethasone) Therapy in Relapsed or Refractory Multiple Myeloma

ClaPD (Clarithromycin/[Biaxin®], Pomalidomide, Dexamethasone) Therapy in Relapsed or Refractory Multiple Myeloma

Discrepancies in Serum Free Light Chain Assays and Immunofixation for Response Evaluation and Prognostication in Plasma Cell Proliferative Disorders

A Phase 1 Study of Bendamustine and Melphalan Conditioning for Autologous Stem Cell Transplant in Multiple Myeloma

T-Bird (thalidomide, clarithromycin/[Biaxin®], lenalidomide/[Revlimid ® ], Dexamethasone) Therapy in Newly Diagnosed Symptomatic Multiple Myeloma

Normalization of the Serum Free Light Chain (FLC) Ratio Is Associated with Superior Overall Survival among Myeloma Patients Achieving Immunofixation Negative State: Results Support Incorporation of Serum FLC Ratio in Stringent CR Definition.

Prevalence and Cause of Death in Patients with Monoclonal Gammopathy in Atomic Bomb Survivors in Hiroshima

A Multidisciplinary Quality Initiative for Stem Cell Transplantation in Multiple Myeloma: Outpatient Transplant with Low Therapy Related Mortality

Treatment of Menigeal Myelomatosis with Liposomal Cytarabine (DepoCyte ® ): A Case Report

Evaluation of Prognostic Factors for Malignant Transformation of Monoclonal Gammopathy of Undetermined Significance

Epidemiology and Clinical Outcomes of the M-Component Immunoglobulin Types of Multiple Myeloma in an Inner City Hispanic Population.

Primary Amyloidosis Treated with Bortezomib with a Clinical and Radiological Response.

A Case of IgM- λ Waldenström’s Macroglobulinemia with Activity Against Phospholipids, Masquerading as Factor V Inhibitor.

Biosynthesis of factor XIII B subunit by human hepatoma cell lines

Induction of delta-aminolevulinic acid dehydratase in mouse Friend virus-transformed erythroleukemia cells during erythroid differentiation

Antigen--antibody complexes related to the baboon endogenous virus in humans with acute lymphoblastic leukemia--hand mirror variant (ALL-HMC)

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only